Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007;2(3):393-8.

Development and results of the Spanish registry of patients with alpha-1-antitrypsin deficiency

Affiliations

Development and results of the Spanish registry of patients with alpha-1-antitrypsin deficiency

Beatriz Lara et al. Int J Chron Obstruct Pulmon Dis. 2007.

Abstract

The Spanish registry of alpha-1 antitrypsin deficiency was founded in 1993 and became a member of the International Registry (AIR) in 1999. We describe the updating process following its incorporation into AIR and compare the data collected in the first period (1993-1999) and the second period (1999-2005), during which time patients were included exclusively by internet. The registry included 301 patients during period 1, 69% males and 46% had a history of smoking. Their mean age was 46 years (SD=13) and 284 (94%) had the ZZ phenotype, 49% received augmentation therapy. During period 2, 161 new cases were included, 63% of whom were males with a mean age of 44 years (SD=16). A total of 126 (78%) had the ZZ phenotype. Only 12% received augmentation therapy. A total of 462 different patients were included in both periods. Significant differences were observed in the number of cases with the SZ phenotype and the severity of FEV1 impairment between the two periods. Implementation of an internet-based collection of data did not result in a lower rate of reporting to the registry. However, data from a significant number of patient included in period 1 could not be actualized in the new data base.

PubMed Disclaimer

References

    1. American Thoracic Society/European Respiratory Society Statement: standards for the diagnosis and management of individuals with Alpha-1 antitrypsin deficiency. Am J Respir Crit Care Med. 2003;168:818–900. - PubMed
    1. Blanco I, de Serres FJ, Fernández-Bustillo E, et al. Estimates of the prevalence of alpha-1-antitrypsin deficiency PI*S and PI*Z alleles and the numbers at risk in Europe countries. Eur Respir J. 2006;27:77–84. - PubMed
    1. Campos MA, Wanner A, Zhang G, et al. Trends in the diagnosis of symptomatic patients with alpha-1 antitrypsin deficiency between 1968 and 2003. Chest. 2005;128:1179–86. - PubMed
    1. Carrel RW, Lomas DA, Sidhar S, et al. α1- Antitrypsin deficiency. A conformational disease. Chest. 1996;110:243S–247S. - PubMed
    1. Costa X, Jardí R, Rodríguez F, et al. Easy method for screening dried blood spot specimens on filter paper for alpha-1 antitrypsin deficiency. Eur Respir J. 2000;15:1111–15. - PubMed

Publication types